Hydrogen peroxide signaling in vascular endothelial cells

Redox Biology

Volumn 2, Issue 1, 2014, Pages 529-534

  Bretón Romero, Rosa ^a   Lamas, Santiago ^a  

^a CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

Author keywords

Endothelium; Hydrogen peroxide; Redox signaling; Vasodilation

Indexed keywords

HYDROGEN PEROXIDE; REACTIVE OXYGEN METABOLITE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; OXIDOREDUCTASE; PROTEIN KINASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; XANTHINE DEHYDROGENASE; XANTHINE OXIDASE;

BLOOD VESSEL FUNCTION; ENDOTHELIUM CELL; HUMAN; INTRACELLULAR SIGNALING; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; VASCULAR ENDOTHELIUM; VASCULARIZATION; ANGIOGENESIS; ANIMAL; BIOLOGICAL MODEL; BLOOD RHEOLOGY; CARDIOVASCULAR DISEASE; CELL DIVISION; METABOLISM; MITOCHONDRION; OXIDATIVE STRESS; PHYSIOLOGY; SIGNAL TRANSDUCTION; VASODILATATION; BLOOD VESSEL TONE; CATALYSIS; CELL GROWTH; CELL METABOLISM; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; MOLECULAR MECHANICS; OXIDATION REDUCTION STATE; SECOND MESSENGER;

ANIMALS; CARDIOVASCULAR DISEASES; CELL DIVISION; ENDOTHELIAL CELLS; HEMORHEOLOGY; HUMANS; HYDROGEN PEROXIDE; MITOCHONDRIA; MODELS, BIOLOGICAL; NADPH OXIDASE; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE SYNTHASE TYPE III; OXIDATION-REDUCTION; OXIDATIVE STRESS; OXIDOREDUCTASES; PROTEIN KINASES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; VASODILATION; XANTHINE DEHYDROGENASE;

EID: 84895750829     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2014.02.005     Document Type: Review

References (103)

1. Cai H., Harrison D.G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circulation Research 2000, 87:840-844. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1161/01.RES.87.10.840.
2. Li J.M., Shah A.M. Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 2004, 287:R1014-R1030. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1152/ajpregu.00124.2004.
3. Cai H. NAD(P)H oxidase-dependent self-propagation of hydrogen peroxide and vascular disease. Circulation Research 2005, 96:818-822. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1161/01.RES.0000163631.07205.fb.
4. Brandes R.P., Kreuzer J. Vascular NADPH oxidases: molecular mechanisms of activation. Cardiovascular Research 2005, 65:16-27. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/j.cardiores.2004.08.007.
5. Griendling K.K. Novel NAD(P)H oxidases in the cardiovascular system. Heart (British Cardiac Society) 2004, 90:491-493. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1136/hrt.2003.029397.
6. Ray P.D., Huang B.W., Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cellular Signalling 2012, 24:981-990. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/j.cellsig.2012.01.008.
7. Finkel T. Oxygen radicals and signaling. Current Opinion in Cell Biology 1998, 10:248-253. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/S0955-0674(98)80147-6.
8. Rhee S.G., Chang T.S., Bae Y.S., Lee S.R., Kang S.W. Cellular regulation by hydrogen peroxide. Journal of the American Society of Nephrology 2003, 14:S211-S215. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1097/01.ASN.0000077404.45564.7E.
9. Janssen-Heininger Y.M., Mossman B.T., Heintz N.H., Forman H.J., Kalyanaraman B., Finkel T., Stamler J.S., Rhee S.G., van der Vliet A. Redox-based regulation of signal transduction: principles, pitfalls, and promises. Free Radical Biology & Medicine 2008, 45:1-17. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/j.freeradbiomed.2008.03.011.
10. D'Autréaux B., Toledano M.B. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nature Reviews. Molecular Cell Biology 2007, 8:813-824. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1038/nrm2256.
11. Cai H. Hydrogen peroxide regulation of endothelial function: origins, mechanisms, and consequences. Cardiovascular Research 2005, 68:26-36. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/j.cardiores.2005.06.021.
12. Takac I., Schröder K., Zhang L., Lardy B., Anilkumar N., Lambeth J.D., Shah A.M., Morel F., Brandes R.P. E-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4. Journal of Biological Chemistry 2011, 286:13304-13313. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1074/jbc.M110.192138.
13. Serrander L., Cartier L., Bedard K., Banfi B., Lardy B., Plastre O., Sienkiewicz A., Fórró L., Schlegel W., Krause K.H. NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation. Biochemical Journal 2007, 406:105-114. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1042/BJ20061903.
14. Brieger K., Schiavone S., Miller F.J., Krause K.H. Reactive oxygen species: from health to disease. Swiss Medical Weekly 2012, 142:w13659. http://www.ncbi.nlm.nih.gov/pubmed/.
15. Burgoyne J.R., Mongue-Din H., Eaton P., Shah A.M. Redox signaling in cardiac physiology and pathology. Circulation Research 2012, 111:1091-1106. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1161/CIRCRESAHA.111.255216.
16. Bedard K., Krause K.H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiological Reviews 2007, 87:245-313. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1152/physrev.00044.2005.
17. Martyn K.D., Frederick L.M., von Loehneysen K., Dinauer M.C., Knaus U.G. Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. Cellular Signalling 2006, 18:69-82. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/j.cellsig.2005.03.023.
18. Altenhöfer S., Kleikers P.W., Radermacher K.A., Scheurer P., Rob Hermans J.J., Schiffers P., Ho H., Wingler K., Schmidt H.H. The NOX toolbox: validating the role of NADPH oxidases in physiology and disease. Cellular and Molecular Life Sciences 2012, 69:2327-2343. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1007/s00018-012-1010-9.
19. Thomas S.R., Witting P.K., Drummond G.R. Redox control of endothelial function and dysfunction: molecular mechanisms and therapeutic opportunities. Antioxidants & Redox Signaling 2008, 10:1713-1765. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1089/ars.2008.2027.
20. Ago T., Kitazono T., Ooboshi H., Iyama T., Han Y.H., Takada J., Wakisaka M., Ibayashi S., Utsumi H., Iida M. Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation 2004, 109:227-233. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1161/01.CIR.0000105680.92873.70.
21. Schröder K., Zhang M., Benkhoff S., Mieth A., Pliquett R., Kosowski J., Kruse C., Luedike P., Michaelis U.R., Weissmann N., Dimmeler S., Shah A.M., Brandes R.P. Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase. Circulation Research 2012, 110:1217-1225. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1161/CIRCRESAHA.112.267054.
22. Brown D.I., Griendling K.K. Nox proteins in signal transduction. Free Radical Biology & Medicine 2009, 47:1239-1253. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/j.freeradbiomed.2009.07.023.
23. Mueller C.F., Laude K., McNally J.S., Harrison D.G. ATVB in focus: redox mechanisms in blood vessels. Arteriosclerosis, Thrombosis, and Vascular Biology 2005, 25:274-278. http://www.ncbi.nlm.nih.gov/pubmed/.
24. Jarasch E.D., Grund C., Bruder G., Heid H.W., Keenan T.W., Franke W.W. Localization of xanthine oxidase in mammary-gland epithelium and capillary endothelium. Cell 1981, 25:67-82. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/0092-8674(81)90232-4.
25. Harrison R. Structure and function of xanthine oxidoreductase: where are we now?. Free Radical Biology & Medicine 2002, 33:774-797. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/S0891-5849(02)00956-5.
26. Granger D.N. Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury. American Journal of Physiology 1988, 255:H1269-H1275. http://www.ncbi.nlm.nih.gov/pubmed/.
27. Guzik T.J., Sadowski J., Guzik B., Jopek A., Kapelak B., Przybylowski P., Wierzbicki K., Korbut R., Harrison D.G., Channon K.M. Coronary artery superoxide production and nox isoform expression in human coronary artery disease. Arteriosclerosis, Thrombosis, and Vascular Biology 2006, 26:333-339. http://www.ncbi.nlm.nih.gov/pubmed/.
28. Spiekermann S., Landmesser U., Dikalov S., Bredt M., Gamez G., Tatge H., Reepschläger N., Hornig B., Drexler H., Harrison D.G. Electron spin resonance characterization of vascular xanthine and NAD(P)H oxidase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. Circulation 2003, 107:1383-1389. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1161/01.CIR.0000056762.69302.46.
29. Godber B.L., Doel J.J., Sapkota G.P., Blake D.R., Stevens C.R., Eisenthal R., Harrison R. Reduction of nitrite to nitric oxide catalyzed by xanthine oxidoreductase. Journal of Biological Chemistry 2000, 275:7757-7763. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1074/jbc.275.11.7757.
30. Li H., Samouilov A., Liu X., Zweier J.L. Characterization of the magnitude and kinetics of xanthine oxidase-catalyzed nitrite reduction. Evaluation of its role in nitric oxide generation in anoxic tissues. Journal of Biological Chemistry 2001, 276:24482-24489. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1074/jbc.M011648200.
31. Vásquez-Vivar J., Kalyanaraman B., Martásek P., Hogg N., Masters B.S., Karoui H., Tordo P., Pritchard K.A. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:9220-9225. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1073/pnas.95.16.9220.
32. Landmesser U., Dikalov S., Price S.R., McCann L., Fukai T., Holland S.M., Mitch W.E., Harrison D.G. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. Journal of Clinical Investigation 2003, 111:1201-1209. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1172/JCI20031417210.1172/JCI14172.
33. Takaya T., Hirata K., Yamashita T., Shinohara M., Sasaki N., Inoue N., Yada T., Goto M., Fukatsu A., Hayashi T., Alp N.J., Channon K.M., Yokoyama M., Kawashima S. A specific role for eNOS-derived reactive oxygen species in atherosclerosis progression. Arteriosclerosis, Thrombosis, and Vascular Biology 2007, 27:1632-1637. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1161/ATVBAHA.107.142182.
34. Higashi Y., Sasaki S., Nakagawa K., Fukuda Y., Matsuura H., Oshima T., Chayama K. Tetrahydrobiopterin enhances forearm vascular response to acetylcholine in both normotensive and hypertensive individuals. American Journal of Hypertension 2002, 15:326-332. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/S0895-7061(01)02317-2.
35. Stroes E., Kastelein J., Cosentino F., Erkelens W., Wever R., Koomans H., Lüscher T., Rabelink T. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. Journal of Clinical Investigation 1997, 99:41-46. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1172/JCI119131.
36. Heitzer T., Schlinzig T., Krohn K., Meinertz T., Münzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001, 104:2673-2678. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1161/hc4601.099485.
37. Finkel T., Holbrook N.J. Oxidants, oxidative stress and the biology of ageing. Nature 2000, 408:239-247. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1038/35041687.
38. Brand M.D. The sites and topology of mitochondrial superoxide production. Experimental Gerontology 2010, 45:466-472. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/j.exger.2010.01.003.
39. Chance B., Sies H., Boveris A. Hydroperoxide metabolism in mammalian organs. Physiological Reviews 1979, 59:527-605. http://www.ncbi.nlm.nih.gov/pubmed/.
40. Lambert A.J., Brand M.D. Reactive oxygen species production by mitochondria. Methods in Molecular Biology 2009, 554:165-181. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1007/978-1-59745-521-3_11.
41. Nemoto S., Takeda K., Yu Z.X., Ferrans V.J., Finkel T. Role for mitochondrial oxidants as regulators of cellular metabolism. Molecular and Cellular Biology 2000, 20:7311-7318. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1128/MCB.20.19.7311-7318.2000.
42. Werner E., Werb Z. Integrins engage mitochondrial function for signal transduction by a mechanism dependent on Rho GTPases. Journal of Cell Biology 2002, 158:357-368. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1083/jcb.200111028.
43. Kluge M.A., Fetterman J.L., Vita J.A. Mitochondria and endothelial function. Circulation Research 2013, 112:1171-1188. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1161/CIRCRESAHA.111.300233.
44. Veal E.A., Day A.M., Morgan B.A. Hydrogen peroxide sensing and signaling. Molecular Cell 2007, 26:1-14. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/j.molcel.2007.03.016.
45. Claiborne A., Miller H., Parsonage D., Ross R.P. Protein-sulfenic acid stabilization and function in enzyme catalysis and gene regulation. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 1993, 7:1483-1490. http://www.ncbi.nlm.nih.gov/pubmed/.
46. Denu J.M., Tanner K.G. Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation. Biochemistry 1998, 37:5633-5642. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1021/bi973035t.
47. 2. Journal of Biological Chemistry 2002, 277:20336-20342. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1074/jbc.M111899200.
48. 2-induced intermolecular disulfide bond formation between receptor protein-tyrosine phosphatases. Journal of Biological Chemistry 2004, 279:44355-44361. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1074/jbc.M407483200.
49. Finkel T. From sulfenylation to sulfhydration: what a thiolate needs to tolerate. Science Signaling 2012, 5:e10. http://www.ncbi.nlm.nih.gov/pubmed/.
50. Holmgren A., Johansson C., Berndt C., Lönn M.E., Hudemann C., Lillig C.H. Thiol redox control via thioredoxin and glutaredoxin systems. Biochemical Society Transactions 2005, 33:1375-1377. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1042/BST20051375.
51. Biteau B., Labarre J., Toledano M.B. ATP-dependent reduction of cysteine-sulphinic acid by S. cerevisiae sulphiredoxin. Nature 2003, 425:980-984. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1038/nature02075.
52. Knock G.A., Ward J.P. Redox regulation of protein kinases as a modulator of vascular function. Antioxidants & Redox Signaling 2011, 15:1531-1547. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1089/ars.2010.3614.
53. Gopalakrishna R., Jaken S. Protein kinase C signaling and oxidative stress. Free Radical Biology and Medicine 2000, 28:1349-1361. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/S0891-5849(00)00221-5.
54. Giannoni E., Buricchi F., Raugei G., Ramponi G., Chiarugi P. Intracellular reactive oxygen species activate Src tyrosine kinase during cell adhesion and anchorage-dependent cell growth. Molecular and Cellular Biology 2005, 25:6391-6403. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1128/MCB.25.15.6391-6403.2005.
55. Denu J.M., Dixon J.E. Protein tyrosine phosphatases: mechanisms of catalysis and regulation. Current Opinion in Chemical Biology 1998, 2:633-641. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/S1367-5931(98)80095-1.
56. Fauman E.B., Saper M.A. Structure and function of the protein tyrosine phosphatases. Trends in Biochemical Sciences 1996, 21:413-417. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/S0968-0004(96)10059-1.
57. Torres M. Mitogen-activated protein kinase pathways in redox signaling. Frontiers in Bioscience :A Journal and Virtual Library 2003, 8:d369-d391. http://www.ncbi.nlm.nih.gov/pubmed/, 10.2741/999.
58. Qi M., Elion E.A. MAP kinase pathways. Journal of Cell Science 2005, 118:3569-3572. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1242/jcs.02470.
59. Colavitti R., Pani G., Bedogni B., Anzevino R., Borrello S., Waltenberger J., Galeotti T. Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR. Journal of Biological Chemistry 2002, 277:3101-3108. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1074/jbc.M107711200.
60. Peshavariya H., Dusting G.J., Jiang F., Halmos L.R., Sobey C.G., Drummond G.R., Selemidis S. NADPH oxidase isoform selective regulation of endothelial cell proliferation and survival. Naunyn-Schmiedeberg's Archives of Pharmacology 2009, 380:193-204. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1007/s00210-009-0413-0.
61. Cai H., Li Z., Davis M.E., Kanner W., Harrison D.G., Dudley S.C. Akt-dependent phosphorylation of serine 1179 and mitogen-activated protein kinase kinase/extracellular signal-regulated kinase 1/2 cooperatively mediate activation of the endothelial nitric-oxide synthase by hydrogen peroxide. Molecular Pharmacology 2003, 63:325-331. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1124/mol.63.2.325.
62. Kevil C.G., Oshima T., Alexander B., Coe L.L., Alexander J.S. H(2)O(2)-mediated permeability: role of MAPK and occludin. American Journal of Physiology. Cell Physiology 2000, 279:C21-C30. http://www.ncbi.nlm.nih.gov/pubmed/.
63. Nguyen A., Chen P., Cai H. Role of CaMKII in hydrogen peroxide activation of ERK1/2, p38 MAPK, HSP27 and actin reorganization in endothelial cells. FEBS Letters 2004, 572:307-313. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/j.febslet.2004.06.061.
64. Cai H., Liu D., Garcia J.G. CaM kinase II-dependent pathophysiological signalling in endothelial cells. Cardiovascular Research 2008, 77:30-34. http://www.ncbi.nlm.nih.gov/pubmed/.
65. Bretón-Romero R., González de Orduña C., Romero N., Sánchez-Gómez F.J., de Álvaro C., Porras A., Rodríguez-Pascual F., Laranjinha J., Radi R., Lamas S. Critical role of hydrogen peroxide signaling in the sequential activation of p38 MAPK and eNOS in laminar shear stress. Free Radical Biology & Medicine 2012, 52:1093-1100. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/j.freeradbiomed.2011.12.026.
66. Huot J., Houle F., Marceau F., Landry J. Oxidative stress-induced actin reorganization mediated by the p38 mitogen-activated protein kinase/heat shock protein 27 pathway in vascular endothelial cells. Circulation Research 1997, 80:383-392. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1161/01.RES.80.3.383.
67. Usatyuk P.V., Vepa S., Watkins T., He D., Parinandi N.L., Natarajan V. Redox regulation of reactive oxygen species-induced p38 MAP kinase activation and barrier dysfunction in lung microvascular endothelial cells. Antioxidants & Redox Signaling 2003, 5:723-730. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1089/152308603770380025.
68. Hirano S., Rees R.S., Yancy S.L., Welsh M.J., Remick D.G., Yamada T., Hata J., Gilmont R.R. Endothelial barrier dysfunction caused by LPS correlates with phosphorylation of HSP27 in vivo. Cell Biology and Toxicology 2004, 20:1-14. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1023/B:CBTO.0000021019.50889.aa.
69. Niwa K., Inanami O., Ohta T., Ito S., Karino T., Kuwabara M. p38 MAPK and Ca2+ contribute to hydrogen peroxide-induced increase of permeability in vascular endothelial cells but ERK does not. Free Radical Research 2001, 35:519-527. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1080/10715760100301531.
70. Lin S.J., Shyue S.K., Liu P.L., Chen Y.H., Ku H.H., Chen J.W., Tam K.B., Chen Y.L. Adenovirus-mediated overexpression of catalase attenuates oxLDL-induced apoptosis in human aortic endothelial cells via AP-1 and c-Jun N-terminal kinase/extracellular signal-regulated kinase mitogen-activated protein kinase pathways. Journal of Molecular and Cellular Cardiology 2004, 36:129-139. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/j.yjmcc.2003.10.011.
71. Chen K., Thomas S.R., Albano A., Murphy M.P., Keaney J.F. Mitochondrial function is required for hydrogen peroxide-induced growth factor receptor transactivation and downstream signaling. Journal of Biological Chemistry 2004, 279:35079-35086. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1074/jbc.M404859200.
72. Ramachandran A., Moellering D., Go Y.M., Shiva S., Levonen A.L., Jo H., Patel R.P., Parthasarathy S., Darley-Usmar V.M. Activation of c-Jun N-terminal kinase and apoptosis in endothelial cells mediated by endogenous generation of hydrogen peroxide. Biological Chemistry 2002, 383:693-701. http://www.ncbi.nlm.nih.gov/pubmed/.
73. Pi X., Yan C., Berk B.C. Big mitogen-activated protein kinase (BMK1)/ERK5 protects endothelial cells from apoptosis. Circulation Research 2004, 94:362-369. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1161/01.RES.0000112406.27800.6F.
74. Darley-Usmar V., White R. Disruption of vascular signalling by the reaction of nitric oxide with superoxide: implications for cardiovascular disease. Experimental Physiology 1997, 82:305-316. http://www.ncbi.nlm.nih.gov/pubmed/.
75. Ramachandran A., Levonen A.L., Brookes P.S., Ceaser E., Shiva S., Barone M.C., Darley-Usmar V. Mitochondria, nitric oxide, and cardiovascular dysfunction. Free Radical Biology & Medicine 2002, 33:1465-1474. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/S0891-5849(02)01142-5.
76. Abid M.R., Kachra Z., Spokes K.C., Aird W.C. NADPH oxidase activity is required for endothelial cell proliferation and migration. FEBS Letters 2000, 486:252-256. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/S0014-5793(00)02305-X.
77. Wung B.S., Cheng J.J., Chao Y.J., Hsieh H.J., Wang D.L. Modulation of Ras/Raf/extracellular signal-regulated kinase pathway by reactive oxygen species is involved in cyclic strain-induced early growth response-1 gene expression in endothelial cells. Circulation Research 1999, 84:804-812. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1161/01.RES.84.7.804.
78. Ushio-Fukai M., Alexander R.W. Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase. Molecular and Cellular Biochemistry 2004, 264:85-97. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1023/B:MCBI.0000044378.09409.b5.
79. 2 in rat heart endothelial cells. Free Radical Biology & Medicine 1998, 25:891-897. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/S0891-5849(98)00115-4.
80. Ushio-Fukai M., Tang Y., Fukai T., Dikalov S.I., Ma Y., Fujimoto M., Quinn M.T., Pagano P.J., Johnson C., Alexander R.W. Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. Circulation Research 2002, 91:1160-1167. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1161/01.RES.0000046227.65158.F8.
81. Griendling K.K., Sorescu D., Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circulation Research 2000, 86:494-501. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1161/01.RES.86.5.494.
82. Abid M.R., Tsai J.C., Spokes K.C., Deshpande S.S., Irani K., Aird W.C. Vascular endothelial growth factor induces manganese-superoxide dismutase expression in endothelial cells by a Rac1-regulated NADPH oxidase-dependent mechanism. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 2001, 15:2548-2550. http://www.ncbi.nlm.nih.gov/pubmed/.
83. Sellke F.W., Simons M. Angiogenesis in cardiovascular disease: current status and therapeutic potential. Drugs 1999, 58:391-396. http://www.ncbi.nlm.nih.gov/pubmed/, 10.2165/00003495-199958030-00001.
84. Antunes F., Cadenas E. Cellular titration of apoptosis with steady state concentrations of H(2)O(2): submicromolar levels of H(2)O(2) induce apoptosis through Fenton chemistry independent of the cellular thiol state. Free Radical Biology & Medicine 2001, 30:1008-1018. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/S0891-5849(01)00493-2.
85. Stone J.R., Collins T. The role of hydrogen peroxide in endothelial proliferative responses. Endothelium: Journal of Endothelial Cell Research 2002, 9:231-238. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1080/10623320214733.
86. 2 in angiotensin II-induced vascular hypertrophy. Hypertension 1998, 32:488-495. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1161/01.HYP.32.3.488.
87. Lee M.Y., Griendling K.K. Redox signaling, vascular function, and hypertension. Antioxidants & Redox Signaling 2008, 10:1045-1059. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1089/ars.2007.1986.
88. Price D.T., Vita J.A., Keaney J.F. Redox control of vascular nitric oxide bioavailability. Antioxidants & Redox Signaling 2000, 2:919-935. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1089/ars.2000.2.4-919.
89. Radi R., Beckman J.S., Bush K.M., Freeman B.A. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. Journal of Biological Chemistry 1991, 266:4244-4250. http://www.ncbi.nlm.nih.gov/pubmed/.
90. Fujimoto S., Asano T., Sakai M., Sakurai K., Takagi D., Yoshimoto N., Itoh T. Mechanisms of hydrogen peroxide-induced relaxation in rabbit mesenteric small artery. European Journal of Pharmacology 2001, 412:291-300. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/S0014-2999(00)00940-7.
91. Gao Y.J., Hirota S., Zhang D.W., Janssen L.J., Lee R.M. Mechanisms of hydrogen-peroxide-induced biphasic response in rat mesenteric artery. British Journal of Pharmacology 2003, 138:1085-1092. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1038/sj.bjp.0705147.
92. Sato A., Sakuma I., Gutterman D.D. Mechanism of dilation to reactive oxygen species in human coronary arterioles. American Journal of Physiology. Heart and Circulatory Physiology 2003, 285:H2345-H2354. http://www.ncbi.nlm.nih.gov/pubmed/.
93. Thengchaisri N., Kuo L. Hydrogen peroxide induces endothelium-dependent and -independent coronary arteriolar dilation: role of cyclooxygenase and potassium channels. American Journal of Physiology. Heart and Circulatory Physiology 2003, 285:H2255-H2263. http://www.ncbi.nlm.nih.gov/pubmed/.
94. Burke T.M., Wolin M.S. Hydrogen peroxide elicits pulmonary arterial relaxation and guanylate cyclase activation. American Journal of Physiology 1987, 252:H721-H732. http://www.ncbi.nlm.nih.gov/pubmed/.
95. Ray R., Murdoch C.E., Wang M., Santos C.X., Zhang M., Alom-Ruiz S., Anilkumar N., Ouattara A., Cave A.C., Walker S.J., Grieve D.J., Charles R.L., Eaton P., Brewer A.C., Shah A.M. Endothelial Nox4 NADPH oxidase enhances vasodilatation and reduces blood pressure in vivo. Arteriosclerosis, Thrombosis, and Vascular Biology 2011, 31:1368-1376. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1161/ATVBAHA.110.219238.
96. Shimokawa H., Matoba T. Hydrogen peroxide as an endothelium-derived hyperpolarizing factor. Pharmacological Research 2004, 49:543-549. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/j.phrs.2003.10.016.
97. Matoba T., Shimokawa H., Nakashima M., Hirakawa Y., Mukai Y., Hirano K., Kanaide H., Takeshita A. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. Journal of Clinical Investigation 2000, 106:1521-1530. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1172/JCI10506.
98. Iida Y., Katusic Z.S. Mechanisms of cerebral arterial relaxations to hydrogen peroxide. Stroke:A Journal of Cerebral Circulation 2000, 31:2224-2230. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1161/01.STR.31.9.2224.
99. Thomas S.R., Chen K., Keaney J.F. Hydrogen peroxide activates endothelial nitric-oxide synthase through coordinated phosphorylation and dephosphorylation via a phosphoinositide 3-kinase-dependent signaling pathway. Journal of Biological Chemistry 2002, 277:6017-6024. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1074/jbc.M109107200.
100. Drummond G.R., Cai H., Davis M.E., Ramasamy S., Harrison D.G. Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide. Circulation Research 2000, 86:347-354. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1161/01.RES.86.3.347.
101. Surks H.K. CGMP-dependent protein kinase I and smooth muscle relaxation:a tale of two isoforms. Circulation Research 2007, 101:1078-1080. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1161/CIRCRESAHA.107.165779.
102. Burgoyne J.R., Madhani M., Cuello F., Charles R.L., Brennan J.P., Schröder E., Browning D.D., Eaton P. Cysteine redox sensor in PKGIa enables oxidant-induced activation. Science 2007, 317:1393-1397. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1126/science.1144318.
103. Burgoyne J.R., Oka S., Ale-Agha N., Eaton P. Hydrogen peroxide sensing and signaling by protein kinases in the cardiovascular system. Antioxidants & Redox Signaling 2013, 18:1042-1052. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1089/ars.2012.4817.